Portfolio Update
The FiveTwenty portfolio received no dividends in the past week.
| Past Week Dividend | $0 |
| Current Quarter Dividend (Q2 2023) | $817.47 |
| LifeTime Dividend | $10,991.05 |
| Estimated Annual Dividend | $9,348.14 |
The capital allocation for the week of 05/28/2023 to 06/03/2023 will be used to add to our position in AbbVie Inc (NYSE: ABBV)
ABBV – Position Update
Since our last check-in on ABBV in week 21 of 2023, there have been no new developments. In addition, the share price declined 5% from $145.11 to $137.56.
| TTM | Prev. Update | 10-year median | |
| Dividend Streak | 511 years | 511 years | |
| Yield | 4.20% | 3.98% | 3.52% |
| Payout Ratio | 44.16%2 | 44.16%2 | |
| P/E | 10.512 | 11.092 |
1 includes the dividend streak ABT before ABBV was spun off, as in independent company the streak is 10 years
2 computed using adjusted EPS of $12.31 as of Q1 2023
Q1 2023 earnings report
Did ABBV’s latest earnings report raise any warning flags?
We discussed ABBV’s Q1 2023 financial results in our previous update. Overall, revenue declines 9.7%, adjusted earnings decreased 22.3%, and adjusted EPS were 22.2% lower.
| Revenue (in millions) | Adj. Net Income (in millions) | Adj. EPS . | |
| Q1 2022 | $13,538 | $5,641 | $3.16 |
| Q1 2023 | $12,225 | $4,385 | $2.46 |
| % Change | (9.7)% | (22.3)% | (22.2)% |
Thesis
Why are we adding to our position in ABBV?
With no new developments our investment thesis remains unchanged. By using this week’s capital allocation, we continue to build our position in the company.
Previous Articles
- 2023 Week 21: AbbVie Inc (NYSE: ABBV)
- 2021 Week 51: AbbVie Inc (NYSE: ABBV)
- 2021 Week 11: AbbVie Inc (NYSE: ABBV)
- 2021 Week 4: AbbVie Inc (NYSE: ABBV)
Additional Research
Photo by Girl with red hat on Unsplash